{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:13:00Z","timestamp":1785442380746,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1124\/jpet.123.001789","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T18:15:11Z","timestamp":1700244911000},"page":"347-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats"],"prefix":"10.1016","volume":"388","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-8817","authenticated-orcid":false,"given":"Lucille A.","family":"Lumley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna A.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio","family":"de Araujo Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-0517","authenticated-orcid":false,"given":"Jerome","family":"Niquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily O.","family":"Linz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3194-5993","authenticated-orcid":false,"given":"Caroline R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-9114","authenticated-orcid":false,"given":"Claude G.","family":"Wasterlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001789_bib1","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3892\/etm.2015.2794","article-title":"Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke","volume":"10","author":"Ahn","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1124\/jpet.123.001789_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nurt.2006.11.006","article-title":"Rufinamide","volume":"4","author":"Arroyo","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.123.001789_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2007.00001.x","article-title":"Lacosamide: a review of preclinical properties","volume":"13","author":"Beyreuther","year":"2007","journal-title":"CNS Drug Rev"},{"key":"10.1124\/jpet.123.001789_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s40262-015-0276-0","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of lacosamide","volume":"54","author":"Cawello","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.123.001789_bib5","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s11064-010-0321-1","article-title":"Post-treatment with voltage-gated Na(+) channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons","volume":"35","author":"Das","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1124\/jpet.123.001789_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneumeth.2009.07.020","article-title":"Analyzing large data sets acquired through telemetry from rats exposed to organophosphorous compounds: an EEG study","volume":"184","author":"de Araujo Furtado","year":"2009","journal-title":"J Neurosci Methods"},{"key":"10.1124\/jpet.123.001789_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2012.09.013","article-title":"Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives","volume":"203","author":"Dorandeu","year":"2013","journal-title":"Chem Biol Interact"},{"key":"10.1124\/jpet.123.001789_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2042098611411127","article-title":"New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?","volume":"2","author":"French","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"10.1124\/jpet.123.001789_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.123.001789_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13602","article-title":"Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na+ channel inactivation","volume":"58","author":"Holtkamp","year":"2017","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001789_bib11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajcp\/75.6.816","article-title":"The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics","volume":"75","author":"Hsu","year":"1981","journal-title":"Am J Clin Pathol"},{"key":"10.1124\/jpet.123.001789_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107832","article-title":"Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS)","volume":"117","author":"Kamitaki","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1124\/jpet.123.001789_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuro.2018.08.011","article-title":"Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes","volume":"69","author":"Lewine","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1124\/jpet.123.001789_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbrc.2022.03.071","article-title":"CRMP2 modulates mossy fiber sprouting in dentate gyrus of pilocarpine induced rat model of epilepsy","volume":"605","author":"Li","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.123.001789_bib15","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/epi.12196","article-title":"Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model","volume":"54","author":"Licko","year":"2013","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001789_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0013-4694(72)90065-X","article-title":"Effect of diazepam upon soman-induced seizure activity and convulsions","volume":"32","author":"Lipp","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1124\/jpet.123.001789_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108444","article-title":"Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors","volume":"185","author":"Lumley","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001789_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.104629","article-title":"Dataset of EEG power integral, spontaneous recurrent seizure and behavioral responses following combination drug therapy in soman-exposed rats","volume":"27","author":"Lumley","year":"2019","journal-title":"Data Brief"},{"key":"10.1124\/jpet.123.001789_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107229","article-title":"Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice","volume":"111","author":"Marrero-Rosado","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1124\/jpet.123.001789_bib20","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/epi.14582","article-title":"Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam","volume":"59","author":"Marrero-Rosado","year":"2018","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001789_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0149-7634(05)80151-4","article-title":"Pharmacological modulation of soman-induced seizures","volume":"17","author":"McDonough","year":"1993","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.123.001789_bib21a","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1124\/jpet.123.001789_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"Suppl 5","key":"10.1124\/jpet.123.001789_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1167.2005.01022.x","article-title":"GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation","volume":"46","author":"Naylor","year":"2005","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001789_bib24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"57","author":"Niquet","year":"2016","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001789_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.123.001789_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/nyas.13147","article-title":"Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment","volume":"1378","author":"Niquet","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.001789_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104537","article-title":"Rational polytherapy in the treatment of cholinergic seizures","volume":"133","author":"Niquet","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.123.001789_bib28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1528-1167.2008.01665.x","article-title":"Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy","volume":"49","author":"Perucca","year":"2008","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001789_bib29","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.3390\/ijms22136981","article-title":"Neuroinflammation: a signature or a cause of epilepsy?","volume":"22","author":"Pracucci","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.123.001789_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0013-4694(73)90033-3","article-title":"Rates of motor seizure development in rats subjected to electrical brain stimulation: strain and inter-stimulation interval effects","volume":"35","author":"Racine","year":"1973","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1124\/jpet.123.001789_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40261-015-0277-7","article-title":"Effect of age and sex on lacosamide pharmacokinetics in healthy adult subjects and adults with focal epilepsy","volume":"35","author":"Schaefer","year":"2015","journal-title":"Clin Drug Investig"},{"key":"10.1124\/jpet.123.001789_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.taap.2012.01.017","article-title":"The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam","volume":"259","author":"Schultz","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.123.001789_bib33","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J Biomed Sci"},{"key":"10.1124\/jpet.123.001789_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.123.001789_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001789_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eplepsyres.2007.03.004","article-title":"Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy","volume":"74","author":"St\u00f6hr","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.123.001789_bib37","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/WNR.0000000000001123","article-title":"Lacosamide modulates collapsin response mediator protein 2 and inhibits mossy fiber sprouting after kainic acid-induced status epilepticus","volume":"29","author":"Wang","year":"2018","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.123.001789_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.eplepsyres.2010.12.014","article-title":"The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus","volume":"94","author":"Wasterlain","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.123.001789_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1535-7511.2009.01336.x","article-title":"Rufinamide: a novel broad-spectrum antiepileptic drug","volume":"10","author":"Wheless","year":"2010","journal-title":"Epilepsy Curr"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:08:54Z","timestamp":1743199734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0022356524171698"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001789","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}